Product
LEO 152020
4 clinical trials
5 indications
Indication
Healthy Control ParticipantsIndication
Cardiac RepolarizationIndication
Cholinergic UrticariaIndication
HealthyIndication
Atopic DermatitisClinical trial
Interventional, Randomised, Partially Double-blind, Crossover, Positive-controlled, Single-dose Trial Investigating the Effect of LEO 152020 on Cardiac Repolarisation in Healthy Men and WomenStatus: Completed, Estimated PCD: 2022-12-28
Clinical trial
Phase 2a Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic UrticariaStatus: Completed, Estimated PCD: 2022-07-08
Clinical trial
A Phase 1, Randomised, Oral Dose Trial to Evaluate the Effect of Food on LEO 152020 in Healthy Adult SubjectsStatus: Completed, Estimated PCD: 2020-12-12
Clinical trial
A Phase 2 Trial to Evaluate the Efficacy and Safety of Orally Administered LEO 152020 Tablets Compared With Placebo Tablets for up to 16 Weeks of Treatment in Adults With Moderate to Severe Atopic DermatitisStatus: Completed, Estimated PCD: 2023-07-20